...for example, seemed neutral on KV7.2/3 modulators.
This approach appears just as promising as the ongoing research involving Psilocybin, MDMA, and tDCS. Additionally, the cost of medical-grade drugs for such treatments is often exorbitant.
Another promising avenue is a spin-off biotech from...